Clinical Trial RESULTS
Clinical Trial
RESULTS
Research Sponsor: AstraZeneca AB
Drugs Studied: Dapagliflozin and metformin
National Clinical Trial #: NCT02637037
Eudra Clinical Trial #: 2015-000448-41
Protocol #: D1691C00008
Study Date: December 2015 to April 2016
Short Study Title: A study to compare 2 different doses of
dapagliflozin and metformin manufactured
at 2 different facilities in healthy participants
with and without food
Thank you!
As a clinical study participant, you belong to a large community of participants around the world. You
help researchers answer important health questions and discover new medical treatments.
Thank you for taking part in the clinical study for the drugs dapagliflozin and metformin. These drugs
are approved to treat type 2 diabetes. You and all of the participants helped researchers learn how the
body affects dapagliflozin and metformin.
AstraZeneca AB, the sponsor of this study, thanks you for your help and thinks it is important for you
to know the results of your study. An independent non-profit organization called CISCRP prepared this
summary of the study results for you with the help of a medical writing organization. We hope that this
summary helps you understand and feel proud of your important role in medical research. If you have
questions about the results, please speak with the doctor or staff at your study site.
11